chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received last shot of Pfizer on 3/21/21 Sunday morning. Zero side effects initially--barely sore arm, no malaise--which is what had happened with first Pfizer shot. On  3/26/21 Friday night around 10PM started itching on knees, then legs, then torso, then everywhere. Bad hives--never had hives before. Couldn't wear clothes. Woke up in the morning  and had scratched myself in my sleep on my arms until I was bruised and spots on my body were bloody. Got some Allegra and took it Saturday morning around 11AM. Got things under control within an hour so I could be functional. But still had welts and was itchy all over. Took Allegra 180mg morning and night through Monday night. Things got better. The following Friday night, 3/26/21, same thing. Body started to itch around 9PM. Welts. Not quite as bad. Took an Allegra 180mg immediately and then morning and night through Sunday night. Not nearly as severe.
I HAD AN ALLERGIC REACTION I HAD A RASH & SWELLING & I CALLED MY DR & WAS TOLD TO TAKE AN EXTRA DOSE OF MY ALLEGRA.
itchy; intermittent pain; bumps and rash on right arm; rash on left cheek; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on left cheek), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE PAIN (intermittent pain) and VACCINATION SITE RASH (bumps and rash on right arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001c21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced RASH (rash on left cheek) and VACCINATION SITE RASH (bumps and rash on right arm). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE PAIN (intermittent pain). At the time of the report, RASH (rash on left cheek), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE PAIN (intermittent pain) and VACCINATION SITE RASH (bumps and rash on right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: NNI
Vasovagal syncope approximately 5 minutes after receiving immunization. Became unresponsive for about 2 minutes with no abnormal movements, loss of bowel or bladder control or vomiting. BP 66/38 HR 57 while unconscious, recovered to 91/59 HR 75 when awake. Had not eaten prior to immunization that morning and likely slightly dehydrated. Drank water and ate a cookie upon awakening and was able to walk out of clinic unassisted approximately 15 minutes later.
cold sore; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, lot Number unknown, expiration date unknown), 1st dose, via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported.  It was reported that on an unspecified date after receiving the first dose of vaccine the patient experienced the cold sore. Caller would like to advise that she took Valacyclovir for her cold sore which was anti-virus. Today (i.e., 07Mar2021) was the schedule for her 2nd dose vaccine. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained
At the time of receiving the vaccination I still had Covid symptoms but was ensured that I can receive the Shingles shot without having to worry. I asked for possible side effects and was ensured that there was 'nothing to worry about' A few weeks later I experienced Bell's Palsy and am now on Steroids.
lightheadedness/dizziness; Hot; sweaty; This is a spontaneous report from a non-contactable other health professional. A 46-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EN6205) via an unspecified route of administration on 18Mar2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 18Mar2021, during her 15 minutes waiting period after the injection, the patient began to experience light-headedness and dizziness. The patient denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. The patient complained of dizziness, hot and sweaty. The treatment given for the reported events included water and ice pack and the patient responded very well to treatment. The patient was discharged and was stable to go home. The clinical outcome of the events light-headedness, hot and sweaty was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: Vaccination facility country was added and lead sentence in narrative was updated to non-contactable healthcare professional.
The pt complained of left upper arm pain with redness and swelling. Time course was about 24 hours. The treatment was ibuprofen/APAP.
Pain in shoulder radiating down arm.  Trouble moving shoulder.  Got worse over the next few days.
I received my second vaccine 2/13/2021. I saw my ophthalmologist 02/15/2021 as a recheck because I fell and hit my head and eye, he noticed my eye pressure increased dramatically. I went back for Laser Treatment on 02/22/2021. I had my left eye done on 2/24/2021. In early March he measured the pressure. My left eye still had a high pressure. On March 25th, The right eye was normal and the left was still high. I had a follow-up appointment on 8/23/2021 and my right eye pressure was normal and the left eye was still high, the doctor had expected it to come down. On  8/25/2021 I had my second laser treatment to my left eye.  My concern is that this may have been caused from the vaccine, because I have never had these issues before. I see the doctor again in 2 weeks. 08/21/21 I received my 3 Covid-19 vaccine and I am waiting to see if my pressures go up again. Third vaccine was Moderna in my left arm. Lot# 051E21A.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, general body pain, weakness, muscle cramp, tingling of extremity and pain in arm. The patient was treated with BENGAY. On an unknown date, the outcome of the injection site pain, general body pain and weakness were recovered/resolved and the outcome of the muscle cramp and tingling of extremity were not recovered/not resolved and the outcome of the pain in arm was unknown. It was unknown if the reporter considered the injection site pain, general body pain, weakness, muscle cramp, tingling of extremity and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but it could be 51 or 52 years old. The patient received her 1st dose of SHINGRIX in an unknown arm. The patient was not sure when she received it, but her calendar notes that she could get the 2nd dose of SHINGRIX anytime after 28th October 2018. After the SHINGRIX vaccine, the patient had pain in her arm at the injection site and also felt weak and achy. The symptoms resolved after a couple of days. More recently the patient had started experiencing muscle cramps in the arm where she received the injection. The patient had been using BENGAY pads on her shoulder, but she had pain and tingling around the injection site and down into her forearm. The patient did not consent to be followed up.
Didn't get the 2nd dose yet/more than 36 days from 1st vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose yet/more than 36 days from 1st vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose yet/more than 36 days from 1st vaccination). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Didn't get the 2nd dose yet/more than 36 days from 1st vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.
This spontaneous report as received from a medical assistant refers to a 9 month old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 17-SEP-2018, the patient was vaccinated with improperly stored dose of ROTATEQ 2 ml tube, orally (lot # N022015, expiry date: 10-MAR-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) and time frame was 3.5 hours from 06-SEP-2018. Previous excursion was 50.37 °F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868: Original Case: 1809USA002868; US-009507513-1902USA009324: Original Case: 1902USA009323; US-009507513-1902USA009323: Original Case: 1902USA009323; US-009507513-1902USA009326: Original Case: 1902USA009323.
Ringing or buzzing noise in my head it started on 03/26/2021 when i woke up that morning. Still have ringing or buzzing in my head today date is 05/04/2021. Never had this problem before the shot!
Developed symptoms of COVID-19 and tested positive with PCR test for COVID-19 on 1-29-2021. Symptoms included cough, rhinorrhea, sore throat, sinus congestion, severe headache, weakness, body aches, N/V/D, fever, chills, night sweats,  abdominal pain. Was quarantined for 10 days post symptom onset.
Patient received the influenza vaccination distributed by GlaxoSmithKline FLULAVAL NDC: 145515-885-07. Patient described symptoms of weakness, muscle weakness, loss of appetite, difficulty with motor coordination, stinging, and burning sensation.
10/7/22 - Patient's mother reported on her right arm vaccination site had two lumps with discoloration and pain. Advice nurse advised to be seen on 10/7/22. 10/14/22 - Saw a pediatrician and at the time felt the reaction appeared to be an expected side effect from vaccination.  Documents right deltoid with ~1.5 cm subcutaneous induration, no significant tenderness and overlying intact skin with bluish/erythematous macular discoloration.  Recommended follow up in one month if persists. 11/3/22 - PCP documenting soft area that feels consistent with keloid formation then a larger dermal indurated lesion that feels consistent with a hematoma and dimpling with movement of the arm as well as discomfort.  Referral to dermatology. 11/4/22 - Pediatric dermatologist finding of pink soft dermal nodule on right upper arm favoring diagnosis of keloid scar.  Trial of Triamcinolone Ointment and massage for 4 weeks.  Plan to patch test for aluminum.
Pt states that she got a red ring around her arm 2 days after her shot. It was tender, bright red, warm and swollen. The band was about 2 inches below the injection site and 1 inch wide. It disappeared after 3 days
Patient stated after pneumonia vaccine he had a fever of 101 - 102.  Arm sore, redness, chills.
Pfizer vaccine that patient was administered had been drawn up between 6 and 7 hours.
Administered pediatric dose to adult pt; 22 year old pt received pediatric dose; This case was reported by a nurse via call center representative and described the occurrence of underdose in a 22-year-old female patient who received HBV (Engerix B pediatric) (batch number 77X47, expiry date 22nd December 2023) for prophylaxis.   On 24th October 2021, the patient received the 2nd dose of Engerix B pediatric. On 24th October 2021, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.  Additional details were provided as follows: The nurse reported that 22 year old patient who received a pediatric dose of Engerix-B, which led to underdose and adult use of a child product. The reporter consented to follow up.
This spontaneous case initially received on 11-Oct-2016, was reported by a health professional and concerns a(n) 45-year-old female patient. Weight: not provided; Height: not provided. She had administered FLUVIRIN in the previous years with no issues. Concomitant medication: refer to appropriate report section. Administration of company suspect drug(s): The patient received AFLURIA from 07-OCT-2016 to 07-OCT-2016 Dose regimen: 0.5 ml once, Route of administration: Intramuscular. Batch number: 149221A. No additional suspect drugs. Adverse reactions/events and outcomes: On 08-Oct-2016 less than 24 hours after receiving the vaccine, the patient experienced flu-like symptoms (malaise, fever, fatigue) (outcome: recovered / resolved), swollen glands and sinus congestion (outcome: not recovered / not resolved). She stated that flu-like symptoms have resolved to date but sinus congestion and swollen glands persisted. Reporter comments: The patient who was also a nurse assessed the events as non-serious.
Pt received vaccine in early AM before hemodialysis RX. That evening (? time), pt stated he had an elevated temp, localized soreness on R arm and general malaise. When seen on 3/8 for HD RX only general malaise persisted. F/U dose on 4/5/07 not given.
Headache started later that day that never went away. It has been 2 weeks. It is a dull throbbing headache. My vision also got blurry.  I was told my cataract in my left eye (left arm was shot) had gotten just a little worse after seeing my ophthalmologist.  I also noticed the cataract originally appeared after using the scopolamine patch  (on my left side) a few years ago.  I don't know if there is a connection. Also, I was told the left eye has become very dry.  I also went to a retinologist, but said the retina seemed okay.
NO ADVERSE EVENT; Doses were administered after the 30 day BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD) and NO ADVERSE EVENT (NO ADVERSE EVENT) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No Medical History information was reported.    In June 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In June 2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (NO ADVERSE EVENT). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD) and NO ADVERSE EVENT (NO ADVERSE EVENT) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (NO ADVERSE EVENT) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Doses were administered after the 30 day BUD).    Concomitant product use was not provided by the reporter.  It was reported that Doses were administered after the 30-day BUD between 8 to 15-Jun-2023. 7 doses were administered, though the clinic was not open on the weekend, so no doses were administered during that weekend. All doses were given to adult patients. There were no reported symptoms or side effects.  Treatment information was not provided.  This case contains information about patient 5th out of 7 adult patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-729901.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-729901:(Master case Patient no-1)
I experienced ringing sensation to my ears, tinnitus.  I have referral to see ENT in beginning of May 2020.
I had my second Pfizer vaccine on 1pm April 23rd. I had headache, nausea and tired feeling from Friday afternoon and it improved Saturday afternoon. Sunday I had a slower but normal day. Monday morning I felt normal but by 2pm I started to feel drowsy and by 4pm the headache and nausea returned to the point I had to go to sleep. This morning I have a light headache and nausea. I have taken Tylenol. Thursday I went to the gym and had higher than normal heartbeat and would get lightheaded. Went to gym today and all is was back to normal.
Dr. had circle wrong vaccines in chart and Medical assistant administered them to the wrong patient that was meant for her older sibling.
Headache, Myalgia, NauseaVomiting, migraine, body aches Narrative:
This spontaneous report as received from a nurse via a company representative refers to a female patient of unknown age. There were unspecified heart conditions run in the patient's family. On an unknown date, the patient the second dose of GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported). On an unknown date, soon after administration of GARDASIL 9, the patient experienced chest pain. On an unknown date, the patient was given an electrocardiogram (EKG) and "echo", which were negative for any heart disease. The patient sought medical attention (unspecified). It was reported that therapy was discontinued. On an unknown date, the patient recovered from the event. The relatedness between the event and GARDASIL 9 was not reported. Additional information has been requested.
Large bruise surrounding site where MMR was injected (a little larger than a softball in size).  His arm is tender to touch but no nodules present.
This spontaneous report was received from the registered nurse refers to an unknown number of patients of unknown age and gender. On an unknown date, the patient was vaccinated with RECOMBIVAX HB (dose, route and lot were not reported). On an unknown date, the patients received improperly stored RECOMBIVAX HB. No adverse symptoms reported. At the time of the report the action taken was not reported. All telephone attempts to obtain follow-up information have been unsuccessful. Follow up information was received from the register nurse on 04-SEP-2014. The register nurse reported vaccine storage temperature dipped to 0-1 degree (units not reported) X 18 different episodes according to the min/max. All recorded temperatures were within 2-8 degrees (units not reported). No adverse events reported. The register nurse reported patient was a female. The patient was vaccinated with the first dose of RECOMBIVAX HB on 27-JUN-2014 at 00:42 hours, lot number J012520, expiration date 31-JAN-2016. The nurse also reported patient did not have siblings. This is one of several reports from the same source. Additional information has been requested.
Patient previously received the first dose of Pfizer (batch/lot# 30145BA) on 10/20/2021. Clinic ran out of Pfizer and could not provide her a 2nd dose of the same series. Patient asked if she may receive Moderna instead. Patient administered a full dose of Moderna (batch/lot# 011F21A) on 11/17/2021, at 16:39; and did not have any allergic reaction or adverse event during 15-min monitoring period nor upon leaving. Moderna batch/lot#11F21A, exp. 1/19/2021.
Had side effects for 10 days.; has no energy; feels "really down"/ feels like my "blood count is low"; hard to keep her eyes open; feeling tired / fatigued; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had side effects for 10 days.), ASTHENIA (has no energy), FEELING ABNORMAL (feels "really down"/ feels like my "blood count is low"), SOMNOLENCE (hard to keep her eyes open) and FATIGUE (feeling tired / fatigued) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Had side effects for 10 days.), ASTHENIA (has no energy), FEELING ABNORMAL (feels "really down"/ feels like my "blood count is low"), SOMNOLENCE (hard to keep her eyes open) and FATIGUE (feeling tired / fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and MULTIVITAMIN [VITAMINS NOS] at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Had side effects for 10 days.), ASTHENIA (has no energy), FEELING ABNORMAL (feels "really down"/ feels like my "blood count is low"), SOMNOLENCE (hard to keep her eyes open) and FATIGUE (feeling tired / fatigued) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow-up information received on 15 Jul 2021 contains updated product information and new events added
1st shot on 05/13/2021: in the next 24 hours, taste changed. It eventually went away 2nd shot on 06/03/2021: in the next 48 hours, ear whooshing sound and nosebleed. It eventually went away
No adverse effects were reported; a 13 years old patient was administered an expired adult dose of VAQTA; a 13 years old patient was administered an expired adult dose of VAQTA; This spontaneous report was received from a registered nurse referring to a 13 year old patient of an unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.     On 14-AUG-2019, the patient was administered an expired adult dose of hepatitis a vaccine, inactivated (VAQTA) lot # R022983 (verified to be a valid lot number), expiration date reported and established as 09-AUG-2019, for prophylaxis. No adverse effects were reported.
fever, redness at site. visited urgent care, diagnosed with infected hematoma and given antibiotic
Fever within 30 minutes of vaccination. Mild hives that re-occurred daily for 10 days. Hives occurred at injection site, on back, neck and groin areas. Rarely more than 3-5 in one location at a time. Flare would last a few hour then receede. By day 10 after vax, no more hives appeared.
Deep fatigue, feverish w/sweating, body aches, intense, intermittent headache, no attention span, could not sleep. Most severe for 30 hours, followed by less frequent, but similar symptoms. 40 hours later "COVID arm", which I had 10 days after initial vaccination.
pt recvd vax 23FEB94 @ 34 days of age, pt devel fever of 102, probably due to occult UTI; hospitalized for a sepsis work-up for 3 days; lab testing revealed WBC count from 7.6 to 24.9 & urine culture pos for group B; streptococcus;